Association of melatonin with nuclear grade and estrogen receptor status in human breast cancer
Maestroni, G.J.M.; Conti, A.
Maestroni, G J M, Conti, A, Reiter, R J Frontiers of Hormone Research; Therapeutic potential of melatonin: 125-131
1997
Accession: 030208073
PDF emailed within 1 workday: $29.90
Related References
Maestroni, G.J.; Conti, A. 1996: Melatonin in human breast cancer tissue: association with nuclear grade and estrogen receptor status Laboratory Investigation; a Journal of Technical Methods and Pathology 75(4): 557-561Pelto Huikko, M.T.; Jarvinen, T.; Holli, K.; Isola, J. 2000: Estrogen receptor B is coexpressed with estrogen receptor A and progesterone receptor and associated with nodal status, grade, and proliferation rate in breast cancer Cell Biology International 24(12): 931
Meulen, N.V.D.; Kalbfleisch, U.; Martin, J.; Proske, H. 1981: Relationship between estrogen receptor status and nuclear rna synthesis in human breast cancer Biochemical Society Transactions 9(2): 313P
Ashton, A.; Katz, R.L.; Patel, S.; Cramer, H.; El Naggar, A.; Gratzner, H. 1988: Correlative studies on needle aspirates of breast cancer using immunocytochemically determined brdurd labelling index with flow cytometry estrogen receptor status and nuclear grade Laboratory Investigation 58(1): 6A
Leake, R.E.; Laing, L.; Mcardle, C.; Smith, D.C. 1981: Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis British Journal of Cancer 43(1): 67-71
Neven, P.; Brouckaert, O.; Van Belle, V.; Vanden Bempt, I.; Hendrickx, W.; Cho, H.; Deraedt, K.; Van Calster, B.; Van Huffel, S.; Moerman, P.; Amant, F.; Leunen, K.; Smeets, A.; Wildiers, H.; Paridaens, R.; Vergote, I.; Christiaens, M-Rose. 2008: In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement Journal of clinical oncology: official journal of the American Society of Clinical Oncology 26(10): 1768-9; author reply 1769-71
Sah, R.G.; Sharma, U.; Parshad, R.; Seenu, V.; Mathur, S.R.; Jagannathan, N.R. 2012: Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study Magnetic Resonance in Medicine 68(4): 1039-1047
Martin, J.H.J.; Begum, S.; Alalami, O.; Harrison, A.; Scott, K.W.M. 2000: Endothelial Nitric Oxide Synthase: Correlation with Histologic Grade, Lymph Node Status and Estrogen Receptor Expression in Human Breast Cancer Tumor Biology 21(2): 90-97
Martin, J.H.; Begum, S.; Alalami, O.; Harrison, A.; Scott, K.W. 2000: Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 21(2): 90-97
Bartlett, J.M.S.; Ellis, I.O.; Johnson, L.; Barrettlee, P.; Ellis, P.; Dowsett, M.; Mallon, E.A.; Cameron, D.A.; Johnston, S.; Hall, E.; Ahern, R.; Peckitt, C.; Bliss, J.M. 2007: Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) : Negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy Journal of Clinical Oncology 25(28): 4423-4430
Bartlett, J.M.S.; Ellis, I.O.; Dowsett, M.; Mallon, E.A.; Cameron, D.A.; Johnston, S.; Hall, E.; A'Hern, R.; Peckitt, C.; Bliss, J.M.; Johnson, L.; Barrett-Lee, P.; Ellis, P. 2007: Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(28): 4423-4430
Li, T.; Sotgia, F.; Vuolo, M.A.; Li, M.; Yang, W.Cai.; Pestell, R.G.; Sparano, J.A.; Lisanti, M.P. 2006: Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status American Journal of Pathology 168(6): 1998-2013
Bao, P-Ping.; Shu, X.Ou.; Gao, Y-Tang.; Zheng, Y.; Cai, H.; Deming, S.L.; Ruan, Z-Xian.; Su, Y.; Gu, K.; Lu, W.; Zheng, W. 2011: Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study American Journal of Epidemiology 174(6): 661-671
Lorgis, V.; Algros, M.P.; Villanueva, C.; Chaigneau, L.; Thierry-Vuillemin, A.; Nguyen, T.; Demarchi, M.; Bazan, F.; Sautiere, J.L.; Maisonnette-Lescot, Y.; Ringenbach, F.; Bontemps, P.; Pivot, X. 2011: Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour Breast 20(3): 284-287
Horwitz, K.B.; Mcguire, W.L. 1978: Mechanisms of estrogen and anti estrogen action in human breast cancer role of nuclear processing of estrogen receptor Clinical Research 26(3): 492A